|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 用于心肌显像的锝阳离子络合物显示文摘近15年来,心血管核医学的研究主要是发展能替代^(201)T1的^(99m)Tc络合物,以扩大心肌灌注技术的临床应用.本文综述了现阶段关于锝阳离子络合物的发展情况,讨论了经动物和人体实验被认为可以作为心肌灌注显像剂的各个^(99m)Tc阳离子络合物,并根据锝离子的氧化态对这些阳离子络合物进行了分类. | Gerundini P Maffioli L 匡琴芳 | 1990 | 国外医学(放射医学核医学分册)1990，14，4： | 2 |
| 2 | Caveolin-1 is essen- tial for metformin inhibitory effect on IGF1 action in non-small- cell lung cancer cells显示文摘 | Salani B Maffioli S Hamoudane M | 2012 | FASEB J2012，26，2： | 1 |
| 3 | Bone scintigra- phy and the added value of SPECT (single photon emis- sion tomography) in detecting skeletal lesions显示文摘 | SaveUi G Maffioli L Maccauro M et 01 | 2001 | Q J Nud Med2001，45，1： | 1 |
| 4 | Acarbose actionson insulin resistance and inflammatory parameters duringan oral fat load显示文摘 | Derosa G Maffioli P Ferrari I | 2011 | Eur J Pharmacol2011，651，123： | 1 |
| 5 | Glycopeptide resistance determinants from the teicoplanin producer Actinoplanes teichomyceticus显示文摘 | Sefina S Radice F Maffioli S | | 0，，01： | 1 |
| 6 | The effect of innovation policy on SMEs' employment and wages in Argentina 显示文摘 | Castillo V Maffioli A Rojo S | 2014 | Small Business Economics2014，42，2： | 1 |
| 7 | Nitricoxide synthase mediates PC 12 differentiationinduced by the surface topography of nanostructuredTi02显示文摘 | Tamplenizza M Lenardi C Maffioli E | 2013 | J Nanobiotechnology2013，11，： | 1 |
| 8 | Effects of amlodipine plus atorvastatinassociation in hypertensive hypercholesterolemic patients显示文摘 | Derosa G Maffioli P | 2014 | ExpertRev Cardiovasc Ther2014，8，6： | 1 |
| 9 | Dipeptidyl Peptidase-4 Inhibitors: 3 years of experience显示文摘 | Giuseppe Derosa Pamela Maffioli | 2012 | Diabetes Technol Ther2012，14，4： | 1 |
| 10 | Bone scintigraphy and the add value of SPECT in detecting skeletal lesions显示文摘 | Maffioli L Maccauro M | 2001 | Q J Nucl Med2001，45，1： | 1 |
| 11 | Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hyperten- sive patients with normal or increased left atrial size显示文摘 | Fogari R Zoppi A Maffioli P et at | 2012 | Clin Cardiol2012，35，6： | 1 |
| 12 | Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 显示文摘 | Derosa G Maffioli P Salvadeo SA | 2010 | Metabolism2010，59，4： | 1 |
| 13 | Heuristics from nature for hard eombinatorial optimization problems显示文摘 | COLOMI A DORIGO M MAFFIOLI F | 1996 | International Transaetions in Operational Researeh1996，3，1： | 1 |
| 14 | Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly con- trolled type 2 diabetic patients 显示文摘 | Derosa G Maffioli P Ferrari I | 2010 | Horm Metab Res2010，42，3： | 1 |
| 15 | A Micro-econometric Analysis of Public Support to Private R&D in Argentina显示文摘 | Chiara Binelli Alessandro Maffioli | 2007 | International Review of Applied Economics2007，，3： | 1 |
| 16 | Efect of antifungalnasal lavage withamphotericin B oil nasalpolyposis显示文摘 | Ricchei A Landis BN Maffioli A | 2002 | J Laryngolotol2002，116，4： | 1 |
| 17 | Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients显示文摘 | Derosa G Maffioli E Ferrari I | 2010 | Horm Metab Res2010，42，9： | 1 |
| 18 | Endoscopic ultrasound-guided drainage of pancreatic fluid collections: The impact of evolving experience and new technologies in diagnosis and treatment over the last two decades显示文摘Background: Endoscopic ultrasound (EUS)-guided drainage is the preferred approach for drainage of pan- creatic uid collections (PFCs) due to the better experience and signi cant progress using newer stents and access devices during last decade. This study aimed to evaluate the role of the evolving experience and possible in uence of new technological devices on the outcome of patients evaluated for PFCs and submitted to EUS-guided drainage during two different periods: the early period at the beginning of experience when a standardized technique was used and the late period when the increased experience of the operator, combined with different stents quality were introduced in the management of PFCs. Methods: We retrospectively analyzed the clinical data of a cohort of 91 consecutive patients, who underwent EUS-guided drainage of symptomatic PFCs from October 2001 to September 2017. Demographic, therapeutic results, complications, and outcomes were compared between early years’ group (2001 2008) and late years’ group (2009 2017). Results: Endoscopic treatment was successfully achieved in 55.6% (20/36) of patients in the early years’ group, and in 96.4% (53/55) in the late years’ group. Eighteen patients (12 in early years’ and 6 in the late year’s group) required additional open surgery. Procedural complications were observed in 5 patients, 4 in early years’ and 1 in late years’ group. Mortality was registered in two patients (2.2%), one for each group. Conclusions: During our long-term survey using EUS-guided endoscopic drainage of PFCs, signi cantly better outcomes in term of improved success rate and decrease complications rate were observed during the late period. | Pietro Gambitta Anna Maffioli Jean Spiropoulos Antonio Armellino Maurizio Vertemati Paolo Aseni | 2020 | Hepatobiliary & Pancreatic Diseases International2020，19，1： | 1 |
| 19 | Exenatide versus glibenclamlde in patients with diabetes显示文摘 | Derosa G Maffioli P Salvadeo SA | | 0，，03： | 1 |
| 20 | Myeloproliferative neoplasms:From JAK-2 mutations discovery to JAK-2 inhibitor therapies显示文摘 | Passamonti F Maffioli M Caramazza D | | 0，，06： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员